Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines

Xin Jin(Mayo Clinic), Kezhen Li(Tongji Hospital)
Oncology Letters
April 13, 2017
Cited by 10


Related Papers